Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study

Our findings suggest that chemotherapy statistically significantly contributes to overall cognitive dysfunction in patients with breast cancer, which disappears after 2-3 years, indicating a recovery in both objectively measurable cognitive function and subjective quality of life. Future research should examine larger sample sizes and explore screening indicators, particularly pNfH.

Authors

Institutions

Publication Details

Journal
The Oncologist
Published
2024-10-14
DOI
https://doi.org/10.1093/oncolo/oyae268
Citations
10
Primary Topic
Cancer-related cognitive impairment studies
Type
article
Field-Weighted Citation Impact
4.19

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study

Adam Dordevic, Nikola Bangemann, Matthias Endres, Christian Schinke et al.
10 citations
The Oncologist
Cancer-related cognitive impairment studies
4.19
article

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study

Adam Dordevic, Nikola Bangemann, Matthias Endres, Christian Schinke, Petra Huehnchen, Jens‐Uwe Blohmer, Bianca Materne, Johannes Steffen Kern, Klemens Ruprecht, Josefine Finck, Carolin Otto, Wolfgang Boehmerle, Jens Göpfert, Anna Kerkmann
article en
10 citations

Abstract

Our findings suggest that chemotherapy statistically significantly contributes to overall cognitive dysfunction in patients with breast cancer, which disappears after 2-3 years, indicating a recovery in both objectively measurable cognitive function and subjective quality of life. Future research should examine larger sample sizes and explore screening indicators, particularly pNfH.

The OncologistVol. 30(2)
German Center for Neurodegenerative Diseases (DE), Humboldt-Universität zu Berlin (DE), Zimmer Biomet (Germany) (DE), Natural and Medical Sciences Institute (DE), German Centre for Cardiovascular Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Medizinische Universität Lausitz - Carl Thiem (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE)
European Federation of Pharmaceutical Industries and Associations, European Commission, Deutsche Forschungsgemeinschaft, Center for Stroke Research Berlin
Openalex Percentile: Top 5%
Cancer-related cognitive impairment studies
4.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.